Epigenetic Regulation of Human Adipose Tissue Distribution

NAActive, not recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 11, 2018

Study Completion Date

December 31, 2025

Conditions
Obesity
Interventions
OTHER

Dual-energy X-ray absorptiometry (DEXA)/ Magnetic resonance imaging (MRI) and Magnetic resonance spectroscopy (MRS)

A DEXA scan for body composition will also be completed. After a MRI safety screening a whole body MRI for the volumetric measurement of visceral fat, subcutaneous fat, liver, kidneys, heart, brain, skeletal muscle and intramuscular adipose tissue (IMAT) and hepatic lipid by MRS will be performed. Whole body imaging will include low resolution positioning images, followed by several sets of 3D images which will be digitally connected to create a 3D image the entire length of the body. The liver spectroscopy will be performed using PRESS (point resolved spectroscopy) and STEAM (Stimulated Echo Acquisition Mode) sequence during the same imaging session, using the whole body images for positioning.

PROCEDURE

Adipose tissue biopsies

Two biopsies will be performed to collect fat tissue from the abdomen and thigh region.

OTHER

FSIGTT/ RMR

Insertion of two intravenous (IV) catheters for performing a Frequently Sampled Intravenous Glucose Tolerance Test (FSIGTT) to measure the acute insulin response to glucose (AIRg) and insulin sensitivity (Si) will be performed. Resting metabolic rate (RMR) will be used to measure metabolic flexibility. Point of care blood glucose measurements will be taken frequently to ensure safety.

Trial Locations (1)

32804

Translational Research Institute for Metabolism and Diabetes, Orlando

All Listed Sponsors
collaborator

Sanford-Burnham Medical Research Institute

OTHER

lead

AdventHealth Translational Research Institute

OTHER

NCT02728635 - Epigenetic Regulation of Human Adipose Tissue Distribution | Biotech Hunter | Biotech Hunter